NCT02036541

AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma

A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 65 (actual)
• Sponsor: AqueSys, Inc. · Industry
• Sex: All
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

To establish the safety and performance of the AqueSys XEN 45 Glaucoma Implant in eyes with refractory glaucoma.

Detailed description

A prospective, multi-center, single arm, open-label clinical trial to evaluate the safety and IOP lowering performance of the AqueSys XEN 45 Glaucoma Implant in refractory glaucoma patients.

Conditions

• Glaucoma
• Glaucoma, Open Angle

Interventions

Type	Name	Description
DEVICE	AqueSys XEN 45 Glaucoma Implant	Placement of the AqueSys XEN 45 Glaucoma Implant in the study eye

Timeline

• Start date: 2013-01-01
• Primary completion: 2016-02-01
• Completion: 2016-08-01
• First posted: 2014-01-15
• Last updated: 2017-06-01
• Results posted: 2017-06-01

Locations

12 sites across 1 country: United States